🟢 Niagen Bioscience is trading 6% up in pre-market with no confirmed catalyst

Niagen Bioscience is trading at $2.50, up +5.93% in pre-market; no stock-specific catalyst has been confirmed.

• U.S. indices are reported higher by more than 0.5%, a possible broader-market backdrop, but no source directly links their strength to the stock’s move.
• Niagen Bioscience is scheduled to release Q3 results after the November 4 market close; results were not available at 6:14 a.m. EST. The earnings preview is upcoming news, not a confirmed explanation for the pre-market rise.